Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.
Vaccine candidates against Shigella dysenteriae type 1, which is associated with the most severe cases of bacillary dysentery, were constructed. The rfp and rfb gene clusters, which code for S. dysenteriae 1 O antigen biosynthesis, were randomly integrated into either the chromosome or the virulence plasmid of the rough attenuated Shigella flexneri aroD strain SFL124-27 with a minitransposon carrying an arsenite resistance selection marker. The recombinant clones efficiently expressed the recombinant O antigen, exhibited a normal growth pattern, were able to invade and survive within eukaryotic cells to the same extent as the parental strain, and expressed the recombinant antigen within invaded cells. A clone was selected as the vaccine candidate, which was demonstrated to be immunogenic and safe in animal models, leading to 47% full protection and 53% partial protection against challenge with the wild-type strain.
Klee
S R
SR
Division of Microbiology, GBF-National Research Centre for Biotechnology, Braunschweig, Germany.
Tzschaschel
B D
BD
Fält
I
I
Kärnell
A
A
Lindberg
A A
AA
Timmis
K N
KN
Guzmán
C A
CA
D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology*; D015139:Blotting, Southern; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D019081:O Antigens / Q000032:analysis; D010957:Plasmids; D012762:Shigella dysenteriae / Q000276:immunology* / Q000472:pathogenicity; D014613:Vaccines, Attenuated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D014774:Virulence
D001428:Bacterial Vaccines; D019081:O Antigens; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic